Literature DB >> 27806912

Quality control in ovarian cancer surgery.

Giovanni D Aletti1, Michele Peiretti2.   

Abstract

The optimal surgical management of patients with ovarian cancer includes a thorough staging with peritoneal and retroperitoneal assessment for early disease stages and a complete debulking with the removal of all macroscopic tumor for advanced disease stages. Disparities across different institutions in terms of optimal surgical management have been described. Surgical quality control programs constitute a real possibility to ensure and improve the quality of the surgery performed. Guidelines for surgery in early and advanced disease stages have been recently reviewed by the National Comprehensive Cancer Network (NCCN), and several quality indicators (QIs) have been proposed. These QIs can be used as a powerful tool to monitor, compare, and improve the quality of surgery across different centers and institutions. Furthermore, a transparent report of surgical outcomes through the creation of National and International Networks, adherence to the NCCN guidelines, and the establishment of quality control programs with a strong training and education component are key factors in enhancing the quality of surgery for patients with ovarian cancer.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  guidelines; optimal surgical care; ovarian cancer; quality indicators

Mesh:

Year:  2016        PMID: 27806912     DOI: 10.1016/j.bpobgyn.2016.08.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  6 in total

1.  Accuracy of radiologic- laparoscopic peritoneal carcinomatosis categorization in the prediction of surgical outcome.

Authors:  Shimaa Abdalla Ahmed; Hisham Abou-Taleb; Noha Ali; Dalia M Badary
Journal:  Br J Radiol       Date:  2019-05-24       Impact factor: 3.039

2.  Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey.

Authors:  Annemie Luyckx; Leen Wyckmans; Anne-Sophie Bonte; Xuan Bich Trinh; Peter A van Dam
Journal:  BMC Womens Health       Date:  2020-07-23       Impact factor: 2.809

3.  Enhancing ovarian cancer care: a systematic review of guideline adherence and clinical variation.

Authors:  Kahren M White; Holly Seale; Reema Harrison
Journal:  BMC Public Health       Date:  2019-03-12       Impact factor: 3.295

4.  An Italian National Survey on Ovarian Cancer Treatment at first diagnosis. There's None so Deaf as those who will not Hear.

Authors:  Vincenzo Dario Mandato; Federica Torricelli; Stefano Uccella; Debora Pirillo; Gino Ciarlini; Gabriele Ruffo; Gianluca Annunziata; Gloria Manzotti; Sandro Pignata; Lorenzo Aguzzoli
Journal:  J Cancer       Date:  2021-05-27       Impact factor: 4.207

5.  Developing an Australian multi-module clinical quality registry for gynaecological cancers: a protocol paper.

Authors:  Natalie Heriot; Alison Brand; Paul Cohen; Sue Hegarty; Simon Hyde; Yee Leung; John R Zalcberg; Robert Rome
Journal:  BMJ Open       Date:  2020-02-27       Impact factor: 2.692

6.  Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.

Authors:  Safiah Ibrahim Althurwi; Jun Q Yu; Philip Beale; Fazlul Huq
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.